Published in Prog Neuropsychopharmacol Biol Psychiatry on January 01, 1986
Modeling Alzheimer's disease with non-transgenic rat models. Alzheimers Res Ther (2013) 0.84
Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis. Exp Brain Res (2005) 0.77
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience (2001) 1.50
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience (2005) 1.14
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav (1996) 1.11
Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science (1989) 1.09
Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol (1996) 1.06
Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat. Neurochem Res (2003) 1.03
Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res (1974) 1.02
Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience (1999) 1.01
Taurine distribution in cat brain. J Neurochem (1972) 1.00
Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem (1993) 0.99
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res (1996) 0.99
Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol (2003) 0.99
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience (2003) 0.98
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience (1997) 0.95
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. Eur J Pharmacol (2001) 0.95
A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res (1996) 0.95
Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem Res (2004) 0.94
A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol (1996) 0.94
Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors. J Med Chem (1998) 0.94
Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia. Eur J Pharmacol (1986) 0.94
Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain. Nucleic Acids Res (1991) 0.93
Effect of adenosine, adenosine triphosphate, adenosine deaminase, dipyridamole and aminophylline on acetylcholine release from electrically-stimulated brain slices. Neuropharmacology (1983) 0.93
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res Bull (1986) 0.93
A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol (1984) 0.92
Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.92
Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res (1998) 0.92
Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and gamma-aminobutyric acid in rat hippocampal slices. J Neurochem (1983) 0.92
Effect of bicuculline and strychnine on the acetylcholine content of the amphibian spinal cord. Br J Pharmacol (1972) 0.92
Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience (1995) 0.91
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol (2009) 0.91
NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res (2001) 0.91
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. J Pharmacol Exp Ther (1998) 0.91
F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile. Br J Pharmacol (2007) 0.90
Fidia and neuroscience. Nature (1993) 0.90
Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol Aging (1988) 0.90
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol Dis (2004) 0.90
Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience (1992) 0.90
Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 0.89
Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res (1997) 0.89
Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol (1982) 0.89
Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res (1999) 0.89
The release of acetylcholine from the brain: an approach to the study of the central cholinergic mechanisms. Prog Neurobiol (1973) 0.88
Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists. Psychopharmacology (Berl) (1999) 0.88
Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res (1994) 0.88
Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci Lett (1995) 0.88
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol (1991) 0.87
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease. Neuroscience (2008) 0.87
Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity. Eur J Pharmacol (1999) 0.87
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur J Neurosci (2000) 0.87
Effects of novelty, pain and stress on hippocampal extracellular acetylcholine levels in male rats. Brain Res (1997) 0.86
Scopolamine induced changes of brain acetylcholine and EEG pattern in cats with complete pontine transection. Arch Ital Biol (1966) 0.86
NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci (1994) 0.86
Investigations into the relationship between phospholipids and brain acetylcholine. Adv Exp Med Biol (1976) 0.86
Beta(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res (1999) 0.85
Acetylcholine input from the cerebral cortex, choline uptake and muscarinic receptors in morphine-dependent, freely-moving rats. Neuropharmacology (1980) 0.85
Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur J Pharmacol (1993) 0.85
Neurotensin modulation of acetylcholine and GABA release from the rat hippocampus: an in vivo microdialysis study. Neurochem Int (1998) 0.85
Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons. Neuroscience (2002) 0.85
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. J Neural Transm (Vienna) (2002) 0.85
Stimulation by morphine of acetylcholine output from the cerebral cortex of septal rats. Brain Res (1975) 0.85
Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res (1995) 0.85
Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms. J Neurochem (1986) 0.84
Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. J Biol Regul Homeost Agents (2010) 0.84
Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem Int (1994) 0.84
Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain. Neuroscience (1998) 0.83
In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors. Eur J Pharmacol (1994) 0.83